These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 5294603

  • 1. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
    Shimamoto T, Atsumi T.
    Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
    [No Abstract] [Full Text] [Related]

  • 2. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R, Pedroni G, Borri P.
    Chir Ital; 1967 Sep; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans].
    Hess H, Goossens N, Keil-Kuri E, Zollner R, Meyer A.
    Vasa; 1972 Sep; 1(3):206-11. PubMed ID: 5076123
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
    Matsumoto K, Sato K, Tanaka S.
    Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J, Hubl S, Godziemba-Maliszewska E.
    Wiad Lek; 1972 Jul 15; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S, Spinella G, Sciacchitanto D.
    Angiologia; 1975 Jul 15; 27(1):7-25. PubMed ID: 1111377
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 12. THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE).
    ABRAMSON DI.
    Heart Bull; 1964 Aug 27; 13():48-51. PubMed ID: 14146982
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of atherosclerosis by pyridinolcarbamate. Review of the history of the introduction of pyridinolcarbamate and its clinical results].
    Shimamoto T.
    Rev Atheroscler (Paris); 1968 Aug 27; 10(3):67-84. PubMed ID: 5746502
    [No Abstract] [Full Text] [Related]

  • 17. Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans.
    Shimamoto T, Atsumi T, Yamashita S, Motomiya T, Isokane N, Ishioka T, Sakuma A.
    Am Heart J; 1970 Jan 27; 79(1):5-19. PubMed ID: 4903137
    [No Abstract] [Full Text] [Related]

  • 18. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A, Bagliani A, Borri P, Ugolini U.
    Clin Ter; 1974 Aug 15; 70(3):281-91. PubMed ID: 4423739
    [No Abstract] [Full Text] [Related]

  • 19. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T, Atsumi T, Isokane N, Yamashita S, Sano T.
    Jpn Heart J; 1970 Sep 15; 11(5):433-49. PubMed ID: 4921577
    [No Abstract] [Full Text] [Related]

  • 20. [Anticardiolipin antibodies in patients with Buerger's disease].
    Cnotliwy M, Gutowski P, Szumiłowicz H, Kucharska E, Jastrzebska M, Ostanek L.
    Wiad Lek; 1999 Sep 15; 52(7-8):332-6. PubMed ID: 10540577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.